160 related articles for article (PubMed ID: 24012721)
1. The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness.
Dautov RF; Ngo DT; Licari G; Liu S; Sverdlov AL; Ritchie RH; Kemp-Harper BK; Horowitz JD; Chirkov YY
Nitric Oxide; 2013 Nov; 35():72-8. PubMed ID: 24012721
[TBL] [Abstract][Full Text] [Related]
2. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
Irvine JC; Cao N; Gossain S; Alexander AE; Love JE; Qin C; Horowitz JD; Kemp-Harper BK; Ritchie RH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H365-77. PubMed ID: 23729209
[TBL] [Abstract][Full Text] [Related]
3. Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.
Miller AA; Maxwell KF; Chrissobolis S; Bullen ML; Ku JM; Michael De Silva T; Selemidis S; Hooker EU; Drummond GR; Sobey CG; Kemp-Harper BK
Free Radic Biol Med; 2013 Jul; 60():264-71. PubMed ID: 23459072
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
5. Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
Borgognone A; Shantsila E; Worrall SM; Prompunt E; Loka T; Loudon BL; Chimen M; Ed Rainger G; Lord JM; Turner A; Nightingale P; Feelisch M; Kirchhof P; Lip GYH; Watson SP; Frenneaux MP; Madhani M
Cardiovasc Res; 2018 Aug; 114(10):1313-1323. PubMed ID: 29659727
[TBL] [Abstract][Full Text] [Related]
6. Effect of nitroxyl on human platelets function.
Bermejo E; Sáenz DA; Alberto F; Rosenstein RE; Bari SE; Lazzari MA
Thromb Haemost; 2005 Sep; 94(3):578-84. PubMed ID: 16268475
[TBL] [Abstract][Full Text] [Related]
7. Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl.
Qin CX; Anthonisz J; Leo CH; Kahlberg N; Velagic A; Li M; Jap E; Woodman OL; Parry LJ; Horowitz JD; Kemp-Harper BK; Ritchie RH
Antioxid Redox Signal; 2020 Jan; 32(1):60-77. PubMed ID: 31680536
[No Abstract] [Full Text] [Related]
8. Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia.
Bullen ML; Miller AA; Dharmarajah J; Drummond GR; Sobey CG; Kemp-Harper BK
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1405-14. PubMed ID: 21803947
[TBL] [Abstract][Full Text] [Related]
9. Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm.
Muminovic A; Chirkov YY; Horowitz JD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298225
[TBL] [Abstract][Full Text] [Related]
10. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
12. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
14. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.
Kemp-Harper BK; Velagic A; Paolocci N; Horowitz JD; Ritchie RH
Handb Exp Pharmacol; 2021; 264():311-337. PubMed ID: 32813078
[TBL] [Abstract][Full Text] [Related]
16. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.
Donzelli S; Fischer G; King BS; Niemann C; DuMond JF; Heeren J; Wieboldt H; Baldus S; Gerloff C; Eschenhagen T; Carrier L; Böger RH; Espey MG
J Pharmacol Exp Ther; 2013 Feb; 344(2):339-47. PubMed ID: 23211362
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
19. Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.
Willoughby SR; Rajendran S; Chan WP; Procter N; Leslie S; Liberts EA; Heresztyn T; Chirkov YY; Horowitz JD
J Am Coll Cardiol; 2012 Sep; 60(10):887-94. PubMed ID: 22682555
[TBL] [Abstract][Full Text] [Related]
20. An ex vivo standardized assay to measure human platelet cGMP.
di Villa Bianca Rd; Mitidieri E; Mirone V; Fusco F; Imbimbo C; Cirino G; Sorrentino R
J Pharmacol Toxicol Methods; 2011; 64(2):164-7. PubMed ID: 21801844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
